Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Carlquist

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Atherosclerosis|March 20, 2012
Vitamin D dependent effects of APOA5 polymorphisms on HDL cholesterolBrian H Shirts, Michael T Howard, Sandra J Hasstedt, et al.
Journal of Cardiac Failure|December 20, 2005
The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failureMatthew J Kolek, John F Carlquist, Surai Thaneemit-Chen, et al.
Molecular Diagnosis & Therapy|April 24, 2015
A Possible Mechanistic Link Between the CYP2C19 Genotype, the Methadone Metabolite Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidene (EDDP), and Methadone-Induced Corrected QT Interval Prolongation in a Pilot StudyJohn F Carlquist, David E Moody, Stacey Knight, et al.
Journal of Thrombosis and Thrombolysis|November 18, 2006
Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective studyJohn F Carlquist, Benjamin D Horne, Joseph B Muhlestein, et al.
American Heart Journal|November 27, 2008
Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utilityJeffrey L Anderson, Benjamin D Horne, Matthew J Kolek, et al.
Journal of Thrombosis and Thrombolysis|July 31, 2007
Rapid melting curve analysis for genetic variants that underlie inter-individual variability in stable warfarin dosingJohn F Carlquist, Jason T McKinney, Zachary P Nicholas, et al.
Cardiology|February 18, 2004
Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease?Jeffrey L Anderson, Benjamin D Horne, Heath U Jones, et al.
American Journal of Nephrology|February 23, 2005
Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary diseaseTroy E Madsen, Joseph B Muhlestein, John F Carlquist, et al.
Annals of Human Genetics|June 9, 2006
High-resolution characterization of linkage disequilibrium structure and selection of tagging single nucleotide polymorphisms: application to the cholesteryl ester transfer protein geneBenjamin D Horne, John F Carlquist, Lisa A Cannon-Albright, et al.
Cardiology|August 31, 2006
Homocysteine levels are associated with increased risk of congestive heart failure in patients with and without coronary artery diseaseHeidi T May, Rami Alharethi, Jeffrey L Anderson, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Atherosclerosis|March 20, 2012
Vitamin D dependent effects of APOA5 polymorphisms on HDL cholesterolBrian H Shirts, Michael T Howard, Sandra J Hasstedt, et al.
Journal of Cardiac Failure|December 20, 2005
The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failureMatthew J Kolek, John F Carlquist, Surai Thaneemit-Chen, et al.
Molecular Diagnosis & Therapy|April 24, 2015
A Possible Mechanistic Link Between the CYP2C19 Genotype, the Methadone Metabolite Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidene (EDDP), and Methadone-Induced Corrected QT Interval Prolongation in a Pilot StudyJohn F Carlquist, David E Moody, Stacey Knight, et al.
Journal of Thrombosis and Thrombolysis|November 18, 2006
Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective studyJohn F Carlquist, Benjamin D Horne, Joseph B Muhlestein, et al.
American Heart Journal|November 27, 2008
Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utilityJeffrey L Anderson, Benjamin D Horne, Matthew J Kolek, et al.
Journal of Thrombosis and Thrombolysis|July 31, 2007
Rapid melting curve analysis for genetic variants that underlie inter-individual variability in stable warfarin dosingJohn F Carlquist, Jason T McKinney, Zachary P Nicholas, et al.
Cardiology|February 18, 2004
Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease?Jeffrey L Anderson, Benjamin D Horne, Heath U Jones, et al.
American Journal of Nephrology|February 23, 2005
Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary diseaseTroy E Madsen, Joseph B Muhlestein, John F Carlquist, et al.
Annals of Human Genetics|June 9, 2006
High-resolution characterization of linkage disequilibrium structure and selection of tagging single nucleotide polymorphisms: application to the cholesteryl ester transfer protein geneBenjamin D Horne, John F Carlquist, Lisa A Cannon-Albright, et al.
Cardiology|August 31, 2006
Homocysteine levels are associated with increased risk of congestive heart failure in patients with and without coronary artery diseaseHeidi T May, Rami Alharethi, Jeffrey L Anderson, et al.
Pageof 9